Why payers, employers still doubt virtual care's lasting impact

The latest stories trending on MedCity News.

Not rendering correctly? View this email as a web page here. TOP STORIES Why Payers and Employers Are Still Doubtful That Virtual Care Will Have a Revolutionary Impact Insurers and employers are optimistic about the possibilities of virtual care, but they're not very enthusiastic about the care modality's larger influence on the healthcare industry, according to a recent report. Just 29% of employers and 34% of payers and benefits consultants said that virtual care will drastically change the way healthcare is provided and outcomes are achieved. Sponsored Content Happening Tomorrow! Collaborating with Expert Physicians to Optimize the Patient Experience From flipMD and MedCity News Join us! November 9, 2022 1pm ET / 10am PT It's no secret that global healthcare is booming, with patient needs evolving alongside societal shifts and the continued pandemic. Join our panel of experts and gain key takeways and more including: The impact that physician insights can make on the patient experience How to tap into those insights to navigate strategic issues or healthcare challenges and ultimately maximize bottom lines How to leverage flipMD's simple and effective platform to recruit expert physicians from a broad range of specialties Not able to attend? We recommend you still register to receive a video recording of the event. A Preview of Healthcare Startups at HLTH 2022 [Sponsored] By Stephanie Baum Tuesday, November 8, 2022 7:30 AM Startups will be plentiful at the upcoming HLTH conference at the Venetian Expo in Las Vegas November 13-16. Here's a glimpse of some of the healthcare pain points they're addressing. Read more » Viatris Sees Vision Drugs as Key to Growth and Commits $750M to Two M&A Deals By Frank Vinluan Monday, November 7, 2022 7:14 PM Two years after the close of the merger that formed Viatris, the company is acquiring Oyster Point Pharma and Famy Life Sciences to expand its scope in ophthalmology, one of three therapeutic areas it is now focusing on for revenue growth. Read more » Supreme Court Will Decide if It Was Legal for a Family to Sue a Nursing Home for Alleged Improper Care By Amanda James Monday, November 7, 2022 5:45 PM Though the case started small, it has gained national attention and more than a dozen states have submitted an amicus brief in support of the Health and Hospital Corporation that operates 78 nursing facilities across Indiana. Read more » 'One Front Door': Headspace Health Launches New Platform Following Merger with Ginger By Marissa Plescia Monday, November 7, 2022 5:30 PM The product — available January 1 — combines Headspace's meditation and mindfulness services with Ginger's coaching, therapy and psychiatry services. It also gives employers insights on their employees' engagement and outcomes. Read more » Debunking Cloud Cost and ROI Hogwash for Healthcare By Gerry Miller Monday, November 7, 2022 4:44 PM The hogwash started in The Wall Street Journal with a contrarian take on a recent KPMG technology report. But cloud operates in a fundamentally different paradigm from the IT infrastructure of the past, and embracing big change is rarely free or easy. But the rewards of evolving are obvious and far too great to ignore. Read more » Highmark, Allegheny Health Network Adopt Cedar's New Tech to Alleviate Billing Confusion By Katie Adams Monday, November 7, 2022 3:48 PM Cedar recently launched a new set of features to bring the disconnected ecosystem of healthcare entities together and make billing easier to understand for patients. Pittsburgh-based payer Highmark Health and its health system, Allegheny Health Network, are the first customers to implement the product, which Cedar dubbed its "payer intelligence layer." Read more » Consumers Need Better Communication From Their Health Plans, Survey Shows By Marissa Plescia Monday, November 7, 2022 1:11 PM More than half, or 58%, of health plan members are "overwhelmed" when it comes to managing their health plans. Insurers need to provide information in a way that's accessible and easy to understand, the report stated. Read more » FDA Pauses Verve's Trial Plan for Gene-Editing Therapy for High Cholesterol By Frank Vinluan Monday, November 7, 2022 11:26 AM The FDA placed a clinical hold on Verve Therapeutics' application to begin human testing of its gene-editing therapy for an inherited form of high cholesterol. No details about the FDA's questions or concerns were disclosed; so far, no serious safety problems have been reported in the U.K. and New Zealand where the clinical trial is already underway. Read more » Guide to Pharmaceutical Contract Management Excellence Today, the pharmaceutical industry is undergoing a rapid and dynamic transformation. Successful contract management plays an instrumental role in navigating this landscape. Download this FREE eBook to learn more! MedCity News   611 Broadway    New York,  NY   10012   United States You received this email because you are subscribed to MedCity Daily Digest from MedCity News. Update your email preferences to choose the types of emails you receive.  Unsubscribe from all future emails